TORONTO, Oct. 30, 2018 /CNW/ - Delivra Corp. (TSXV:
DVA - "Delivra" or the "Company"), a science and biotechnology
company, today announced that its Founder and CEO, Dr. Joseph Gabriele, is the recipient of the Ernst
& Young Entrepreneur Of The Year 2018 Ontario award in the
Health Care category.
"I'm humbled and honoured by the award", said Joseph Gabriele. "I'm grateful to the Delivra
team who are the true heroes. I'm proud that EY has recognized the
capabilities of our unique patented delivery system,
DelivraTM, for pharmaceutical and natural molecules
across a spectrum of medical and consumer products capabilities.
Delivra was born out of a need to help my wife who was debilitated
by post-surgery pain, hence the genesis of our novel topical
solution. She feared the addictive powers of opioids and couldn't
take oral medications due to digestive challenges. Today,
Delivra helps many pain suffers in Canada and internationally. We also have an
over-the-counter product line, called LivReliefTM, and
just launched a new Extra Strength Chronic Angry Pain cream,
as well as a unique new Sports & Active cream. In our
pharmaceutical division, we are helping patients that are suffering
with pain related to medical issues, including diabetes, and we
have the capability of delivering cannabis and CBD to both humans
and animals, topically and effectively. Our mission is to help pain
sufferers reclaim their lives back. We are excited about the future
and our proven capability and potential to help millions of
people."
"Companies in the health care sector face a challenging and
competitive landscape," says Paula
Smith, EY Entrepreneur Of The Year Ontario Program
Co-Director. "Canada, in
particular, has an aging population and growing demand for patient
care, pushing entrepreneurs to respond quickly and thoughtfully
with innovative solutions to meet changing needs."
"Delivra is doing just that," adds Elena Doucette, EY Entrepreneur Of The Year
Ontario Program Co-Director. "They're revolutionizing the
delivery of pain relief, and doing it in a safer and more effective
way for those in need. We're proud to have recognized the
outstanding work Joseph is doing in the health care sector."
ABOUT DELIVRA CORP.
Delivra Corp. is a specialty biotechnology company having a
proprietary transdermal delivery system platform that can shuttle
pharmaceutical and natural molecules through the skin, in a
targeted manner. Delivra manufactures and sells a growing line of
natural topical creams with the proprietary transdermal delivery
system platform under the LivReliefTM brand, for
conditions such as joint and muscle pain, nerve pain, varicose
veins, wound healing, and under the LivSportTM brand for
sports performance. LivReliefTM products are available
in pharmacies, grocery chains, and independent health food stores
across Canada, including, but not
limited to, Shoppers Drug Mart, Walmart, Loblaw, Rexall,
Pharmasave, London Drugs, and on-line at www.livrelief.com. In
parallel with its consumer products business, Delivra also has a
mandate to license its patent-pending, proprietary transdermal
delivery technology platform to pharmaceutical companies globally,
for the repurposing of pharmaceutical molecules transdermally to
treat a broad range of conditions, along with licensing its
over-the-counter products globally. Delivra is headquartered in
Hamilton, Ontario and has a
research and development laboratory in Charlottetown, Prince Edward Island.
Further information on Delivra can be found at
www.delivracorp.com and www.livrelief.com.
About EY Entrepreneur Of The Year®
EY Entrepreneur Of The Year® is the world's most
prestigious business awards program for entrepreneurs. The program
makes a difference through the way it encourages entrepreneurial
activity among those with potential and recognizes the contribution
of people who inspire others with their vision, leadership and
achievement. As the first and only truly global awards program of
its kind, Entrepreneur Of The Year celebrates those who are
building and leading successful, growing and dynamic businesses,
recognizing them through regional, national and global awards
programs in more than 145 cities in more than 50
countries. ey.com/ca/EOY
Neither the TSX Venture Exchange nor its
Regulation Services Provider (as that term is defined in the
policies of the TSX Venture Exchange) accepts
responsibility for the adequacy or accuracy of this
release.
SOURCE Delivra Corp